Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
暂无分享,去创建一个
Rajarsi R. Gupta | N. Halama | J. A. van der Laak | N. Rajpoot | M. Salto‐Tellez | J. Hartman | E. Thompson | C. Sotiriou | Marvin Lerousseau | S. Loi | D. Larsimont | L. Pusztai | P. V. van Diest | A. Madabhushi | H. Horlings | J. Reis-Filho | A. Vincent-Salomon | E. Hytopoulos | D. Rimm | M. Amgad | L. Cooper | E. Balslev | S. Dudgeon | Yinyin Yuan | K. AbdulJabbar | P. Savas | F. Ciompi | D. Moore | J. Lennerz | Pawan Kirtani | G. Pruneri | S. Demaria | S. Adams | S. Loibl | Z. Kos | M. Hanna | S. Michiels | R. Salgado | A. Hida | A. Grigoriadis | A. Laenkholm | B. Ács | E. Bellolio | G. Broeckx | J. Giltnane | K. Siziopikou | K. Blenman | K. Korski | S. Irshad | S. Fineberg | Wentao Yang | W. Tran | Z. Husain | T. Taxter | A. Dahl | S. Tejpar | F. Symmans | J. Saltz | S. Hart | T. Rau | A. Harbhajanka | A. Coosemans | S. Sayed | E. Janssen | S. Gnjatic | Germán Corredor | T. Tramm | W. Gallagher | J. Teuwen | Arman Rahman | C. Jahangir | I. Alvarado-Cabrero | A. Khramtsov | N. Wahab | A. Kovács | Shachi Mittal | B. Rapoport | L. Kodach | A. Ly | Guray Akturk | D. Marks | Thomas Walter | F. Penault-Llorca | Søren Hauberg | T. Ebstrup | A. Roslind | E. McDonald | M. Sughayer | Xiaoxian Li | Sara Verbandt | T. Kataoka | Daniel G Sur | K. Kawaguchi | G. Acosta Haab | H. Wen | Reena Khiroya | M. Kahila | T. Papathomas | G. Viale | Y. Waumans | Umay Kiraz | O. Burgués | Sunao Tanaka | Najat Bouchmaa | S. Badve | S. Fox | R. Zin | C. Lang-Schwarz | C. Pinard | Durga Kharidehal | Ravi Mehrotra | C. Denkert | V. Bheemaraju | F. Minhas | J. Thagaard | Rashindrie Perera | Farid Azmoudeh-Ardalan | Shamim Mushtaq | Jonas S. Almeida | F. Deman | Paula I. González-Ericsson | S. Maley | Stephen M. Hewitt | Elisabeth Specht Stovgaard | A. Stenzinger | Claudio Fernandez-Martín | M. Vieth | D. B. Page | John M. S. Bartlett | Rajarsi Gupta | Nurkhairul Bariyah Baharun | Luciana Botinelly Mendonça Fujimoto | Alexandros Chardas | Maggie Chon U Cheang | Flavio Luis Dantas Portela | Johan Doré Hansen | Mahmoud Elghazawy | Zaheed Husain | Vidya Manur Narasimhamurthy | Hussain Nighat | Juan Carlos Pinto-Cardenas | J. M. Ribeiro | Ely Scott | G. Verghese | E. Scott | Paula I. Gonzalez-Ericsson | Konstanty Korski | Corinna Lang-Schwarz | D. Page
[1] Sung-Bae Kim,et al. Abstract PD9-05: Stromal tumor-infiltrating lymphocytes identify early-stage triple-negative breast cancer patients with favorable outcomes at 10-year follow-up in the absence of systemic therapy: a pooled analysis of 1835 patients , 2023, Cancer Research.
[2] Mohamed Atef AlMoslemany,et al. NuCLS: A scalable crowdsourcing approach and dataset for nucleus classification and segmentation in breast cancer , 2022, GigaScience.
[3] Rajarsi R. Gupta,et al. Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression , 2022, Cancers.
[4] Rajarsi R. Gupta,et al. Deep Learning-Based Mapping of Tumor Infiltrating Lymphocytes in Whole Slide Images of 23 Types of Cancer , 2022, Frontiers in Oncology.
[5] E. Provenzano,et al. Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer , 2021, Cancers.
[6] J. Hartman,et al. What do we still need to learn on digitally assessed biomarkers? , 2021, EBioMedicine.
[7] Jakob Nikolas Kather,et al. The impact of site-specific digital histology signatures on deep learning model accuracy and bias , 2021, Nature Communications.
[8] Shuoyu Xu,et al. A Computational Tumor-Infiltrating Lymphocyte Assessment Method Comparable with Visual Reporting Guidelines for Triple-Negative Breast Cancer , 2021, EBioMedicine.
[9] Mohsin Bilal,et al. Semantic annotation for computational pathology: multidisciplinary experience and best practice recommendations , 2021, The journal of pathology. Clinical research.
[10] J. Hartman,et al. An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer , 2021, Clinical Cancer Research.
[11] E. S. Stovgaard,et al. Automated Quantification of sTIL Density with H&E-Based Digital Image Analysis Has Prognostic Potential in Triple-Negative Breast Cancers , 2021, Cancers.
[12] G. Litjens,et al. Deep learning in histopathology: the path to the clinic , 2021, Nature Medicine.
[13] Jeroen van der Laak,et al. Residual cyclegan for robust domain transformation of histopathological tissue slides , 2021, Medical Image Anal..
[14] Ny,et al. NuCLS: A scalable crowdsourcing approach and dataset for nucleus classification and segmentation in breast cancer , 2021, GigaScience.
[15] G. Litjens,et al. Optimized tumour infiltrating lymphocyte assessment for triple negative breast cancer prognostics , 2021, Breast.
[16] D. Kerr,et al. Designing deep learning studies in cancer diagnostics , 2021, Nature Reviews Cancer.
[17] Australia,et al. A Pathologist-Annotated Dataset for Validating Artificial Intelligence: A Project Description and Pilot Study , 2020, Journal of pathology informatics.
[18] Yi-long Wu,et al. Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1+CD8+ and CD8+ T cells as predictive of response to neoadjuvant chemotherapy in breast cancer , 2020, Thoracic cancer.
[19] Alexi Baidoshvili,et al. Impact of rescanning and normalization on convolutional neural network performance in multi-center, whole-slide classification of prostate cancer , 2020, Scientific Reports.
[20] Andrew H. Beck,et al. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer , 2020, npj Breast Cancer.
[21] Andrew H. Beck,et al. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group , 2020, npj Breast Cancer.
[22] Jacqueline A. Hall,et al. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials , 2020, npj Breast Cancer.
[23] Zhi Han,et al. Deep-Learning–Based Characterization of Tumor-Infiltrating Lymphocytes in Breast Cancers From Histopathology Images and Multiomics Data , 2020, JCO clinical cancer informatics.
[24] Roger R. Wang,et al. Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis , 2020, PloS one.
[25] Geert J. S. Litjens,et al. Efficient Out-of-Distribution Detection in Digital Pathology Using Multi-Head Convolutional Neural Networks , 2020, MIDL.
[26] Anne L. Martel,et al. Deep neural network models for computational histopathology: A survey , 2019, Medical Image Anal..
[27] Reika Takamatsu,et al. Quantitative digital image analysis of tumor-infiltrating lymphocytes in HER2-positive breast cancer , 2019, Virchows Archiv.
[28] Geert J. S. Litjens,et al. Learning to detect lymphocytes in immunohistochemistry with deep learning , 2019, Medical Image Anal..
[29] Andrew H. Beck,et al. Computational pathology definitions, best practices, and recommendations for regulatory guidance: a white paper from the Digital Pathology Association , 2019, The Journal of pathology.
[30] Claes Lundström,et al. A Closer Look at Domain Shift for Deep Learning in Histopathology , 2019, ArXiv.
[31] Ashish Sharma,et al. Utilizing Automated Breast Cancer Detection to Identify Spatial Distributions of Tumor Infiltrating Lymphocytes in Invasive Breast Cancer , 2019, The American journal of pathology.
[32] Consuelo Morigi,et al. Highlights of the 16th St Gallen International Breast Cancer Conference, Vienna, Austria, 20–23 March 2019: personalised treatments for patients with early breast cancer , 2019, Ecancermedicalscience.
[33] Geert J. S. Litjens,et al. Quantifying the effects of data augmentation and stain color normalization in convolutional neural networks for computational pathology , 2019, Medical Image Anal..
[34] Jonathan D. Beezley,et al. Structured crowdsourcing enables convolutional segmentation of histology images , 2019, Bioinform..
[35] L. Russo,et al. Locally advanced breast cancer: Tumor-infiltrating lymphocytes as a predictive factor of response to neoadjuvant chemotherapy. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[36] Anindya Sarkar,et al. Joint region and nucleus segmentation for characterization of tumor infiltrating lymphocytes in breast cancer , 2019, Medical Imaging.
[37] Heikki Joensuu,et al. Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] Timo Kohlberger,et al. Whole-Slide Image Focus Quality: Automatic Assessment and Impact on AI Cancer Detection , 2019, Journal of pathology informatics.
[39] Navid Farahani,et al. A Practical Guide to Whole Slide Imaging: A White Paper From the Digital Pathology Association. , 2018, Archives of pathology & laboratory medicine.
[40] Meyke Hermsen,et al. 1399 H&E-stained sentinel lymph node sections of breast cancer patients: the CAMELYON dataset , 2018, GigaScience.
[41] P. Heikkilä,et al. Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study , 2018, Breast Cancer Research and Treatment.
[42] Rajarsi R. Gupta,et al. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images. , 2018, Cell reports.
[43] S. Sleijfer,et al. Breast cancer genomics and immuno-oncological markers to guide immune therapies. , 2017, Seminars in cancer biology.
[44] Ross B. Girshick,et al. Mask R-CNN , 2017, 1703.06870.
[45] Zhen-ning Wang,et al. Mechanism of immune evasion in breast cancer , 2017, OncoTargets and therapy.
[46] Bram van Ginneken,et al. A survey on deep learning in medical image analysis , 2017, Medical Image Anal..
[47] Peter Bankhead,et al. QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.
[48] Jianxu Chen,et al. Automatic Lymphocyte Detection in H&E Images with Deep Neural Networks , 2016, ArXiv.
[49] M. Disis,et al. Clinical significance of tumor-infiltrating lymphocytes in breast cancer , 2016, Journal of Immunotherapy for Cancer.
[50] S. Adams,et al. Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review. , 2016, JAMA oncology.
[51] Carsten Denkert,et al. Clinical relevance of host immunity in breast cancer: from TILs to the clinic , 2016, Nature Reviews Clinical Oncology.
[52] Andrew Janowczyk,et al. Deep learning for digital pathology image analysis: A comprehensive tutorial with selected use cases , 2016, Journal of pathology informatics.
[53] T. Nielsen,et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[54] Siew Hooi Tan,et al. Kuala Lumpur, Malaysia , 2012 .
[55] F. Markowetz,et al. Quantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling , 2012, Science Translational Medicine.
[56] Gyan Bhanot,et al. Computerized Image-Based Detection and Grading of Lymphocytic Infiltration in HER2+ Breast Cancer Histopathology , 2010, IEEE Transactions on Biomedical Engineering.
[57] Stephen B Fox,et al. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[58] L. R. Macfarlane,et al. Department of pathology , 1961, Journal of the Royal Army Medical Corps.
[59] M. Cigéhn,et al. Quality control of whole-slide images through multi-class semantic segmentation of artifacts , 2021 .
[60] Søren Hauberg,et al. Can You Trust Predictive Uncertainty Under Real Dataset Shifts in Digital Pathology? , 2020, MICCAI.
[61] Amal Al-Omari. Clinical Research Management at the King Hussein Cancer Center, Amman, Jordan , 2017 .
[62] Robert W. Lucky,et al. The Grand Challenge , 1993 .
[63] K. Jenpanich,et al. [Drug administration]. , 1976, Thai journal of nursing.